Evidence map›Paper›PMID 26437080›Full record

ArticleLeukemia & lymphoma2016

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status.

Samantha Kendrick, Katalin Tus, George Wright, Elaine S Jaffe, Andreas Rosenwald, Elías Campo, Wing Chung Chan, Joseph M Connors, Rita M Braziel, German Ott and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  2. Article
  3. Article
  4. Review
  5. Clinical applications of genome studies.Hematological oncology · 2017
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Samantha Kendricka Department of Pathology , University of Arizona , Tucson , AZ , USA .
Katalin Tusa Department of Pathology , University of Arizona , Tucson , AZ , USA .
George Wrightb National Cancer Institute , Bethesda , MD , USA .
Elaine S Jaffec Laboratory of Pathology , National Cancer Institute , Bethesda , MD , USA .
Andreas Rosenwaldd Institute of Pathology, University of Wuerzburg, and Comprehensive Cancer Center Mainfranken , Wuerzburg , Germany .
Elías Campoe Department of Pathology , Hospital Clínic , Barcelona , Spain .
Wing Chung Chanf Department of Pathology , City of Hope National Medical Center , Duarte , CA , USA .
Joseph M Connorsg Centre for Lymphoid Cancer, British Columbia Cancer Agency , Vancouver , BC , Canada .
Rita M Brazielh Department of Clinical Pathology , Oregon Health & Science University , Portland , OR , USA .
German Otti Department of Clinical Pathology , Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology , Stuttgart , Germany .
Jan Delabiej Department of Pathology , Oslo University Hospital, Radiumhospitalet , Oslo , Norway .
James R Cookk Department of Molecular Pathology and Laboratory Medicine , Cleveland Clinic , Cleveland , OH , USA .
Dennis D Weisenburgerf Department of Pathology , City of Hope National Medical Center , Duarte , CA , USA .
Timothy C Greinerl Department of Pathology and Microbiology , University of Nebraska Medical Center , Omaha , NE , USA .
Kai Ful Department of Pathology and Microbiology , University of Nebraska Medical Center , Omaha , NE , USA .
Louis M Staudtm Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Health Institutes , Bethesda , MD , USA , and.
Randy D Gascoyneg Centre for Lymphoid Cancer, British Columbia Cancer Agency , Vancouver , BC , Canada .
David W Scottg Centre for Lymphoid Cancer, British Columbia Cancer Agency , Vancouver , BC , Canada .
Lisa M Rimszaa Department of Pathology , University of Arizona , Tucson , AZ , USA .

Funding

Lymphoma Disease Discovery and DefintionZIASC000550 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$16.9M
Hematopathology DiagnosisZIABC011070 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI JAFFE, ELAINE · 2009 to 2025
$14.5M
Molecular Diagnosis and Prognosis in Aggressive LymphomaU01CA157581 · NCI · UNIVERSITY OF ARIZONA · PI RIMSZA, LISA · 2011 to 2015
$3.1M
NCI NIH HHS 1U01CA157581-01NCI NIH HHS U01 CA157581
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene ExpressionGene Expression ProfilingHumansLymphoma, Large B-Cell, DiffusePrognosisProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-myc

Identifiers

PMID26437080
PMCPMC5937932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.